Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Vacuum Cleaners That Are Not difficult To Use For Home - 2Saturn's moon Titan may not have a buried ocean as long suspected, new study suggests
- 3Investigating Remarkable Espresso Flavors: Upgrade Your Day to day Blend
- 4Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes
- 57 Strange Apparatuses to Make Your Party Stick Out!
- Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- Find the Captivating Professional flowerbeds of the US
- Manual for Wonderful Getaway destination
- A few Exemplary Chinese Dishes, Which Are Famous Around the world
- The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise...
- As tetanus vaccination rates decline, doctors worry about rising case numbers
- Artemis II astronauts are more than halfway to the moon as they seek to break Apollo 13's record
- Churches and politicians in South Sudan call for 'lasting peace' in Easter messages
- The most effective method to Redesign the Sound Framework in Your Smash 1500.
